Prediction of electroconvulsive therapy response and remission in major depression: meta-analysis. 2018

Linda van Diermen, and Seline van den Ameele, and Astrid M Kamperman, and Bernard C G Sabbe, and Tom Vermeulen, and Didier Schrijvers, and Tom K Birkenhäger
Collaborative Antwerp Psychiatric Research Institue (CAPRI),Department of Biomedical Sciences,University of Antwerp,Belgium.

Electroconvulsive therapy (ECT) is considered to be the most effective treatment in severe major depression. The identification of reliable predictors of ECT response could contribute to a more targeted patient selection and consequently increased ECT response rates. Aims To investigate the predictive value of age, depression severity, psychotic and melancholic features for ECT response and remission in major depression. A meta-analysis was conducted according to the PRISMA statement. A literature search identified recent studies that reported on at least one of the potential predictors. Of the 2193 articles screened, 34 have been included for meta-analysis. Presence of psychotic features is a predictor of ECT remission (odds ratio (OR) = 1.47, P = 0.001) and response (OR = 1.69, P < 0.001), as is older age (standardised mean difference (SMD) = 0.26 for remission and 0.35 for response (P < 0.001)). The severity of depression predicts response (SMD = 0.19, P = 0.001), but not remission. Data on melancholic symptoms were inconclusive. ECT is particularly effective in patients with depression with psychotic features and in elderly people with depression. More research on both biological and clinical predictors is needed to further evaluate the position of ECT in treatment protocols for major depression. Declaration of interest None.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011618 Psychotic Disorders Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994) Psychoses,Psychosis, Brief Reactive,Schizoaffective Disorder,Schizophreniform Disorders,Psychosis,Brief Reactive Psychoses,Brief Reactive Psychosis,Disorder, Psychotic,Disorder, Schizoaffective,Disorder, Schizophreniform,Disorders, Psychotic,Disorders, Schizoaffective,Disorders, Schizophreniform,Psychoses, Brief Reactive,Psychotic Disorder,Reactive Psychoses, Brief,Reactive Psychosis, Brief,Schizoaffective Disorders,Schizophreniform Disorder
D012074 Remission Induction Therapeutic act or process that initiates a response to a complete or partial remission level. Induction of Remission,Induction, Remission,Inductions, Remission,Remission Inductions
D003865 Depressive Disorder, Major Disorder in which five (or more) of the following symptoms have been present during the same 2-week period and represent a change from previous functioning; at least one of the symptoms is either (1) depressed mood or (2) loss of interest or pleasure. Symptoms include: depressed mood most of the day, nearly every daily; markedly diminished interest or pleasure in activities most of the day, nearly every day; significant weight loss when not dieting or weight gain; Insomnia or hypersomnia nearly every day; psychomotor agitation or retardation nearly every day; fatigue or loss of energy nearly every day; feelings of worthlessness or excessive or inappropriate guilt; diminished ability to think or concentrate, or indecisiveness, nearly every day; or recurrent thoughts of death, recurrent suicidal ideation without a specific plan, or a suicide attempt. (DSM-5) Depression, Involutional,Major Depressive Disorder,Melancholia, Involutional,Paraphrenia, Involutional,Psychosis, Involutional,Depressive Disorders, Major,Involutional Depression,Involutional Melancholia,Involutional Paraphrenia,Involutional Paraphrenias,Involutional Psychoses,Involutional Psychosis,Major Depressive Disorders,Paraphrenias, Involutional,Psychoses, Involutional
D004565 Electroconvulsive Therapy Electrically induced CONVULSIONS primarily used in the treatment of severe AFFECTIVE DISORDERS and SCHIZOPHRENIA. Convulsive Therapy, Electric,ECT (Psychotherapy),Electroshock Therapy,Shock Therapy, Electric,Convulsive Therapies, Electric,Electric Convulsive Therapies,Electric Convulsive Therapy,Electric Shock Therapies,Electric Shock Therapy,Electroconvulsive Therapies,Electroshock Therapies,Shock Therapies, Electric,Therapies, Electric Convulsive,Therapies, Electric Shock,Therapies, Electroconvulsive,Therapies, Electroshock,Therapy, Electric Convulsive,Therapy, Electric Shock,Therapy, Electroconvulsive,Therapy, Electroshock
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Linda van Diermen, and Seline van den Ameele, and Astrid M Kamperman, and Bernard C G Sabbe, and Tom Vermeulen, and Didier Schrijvers, and Tom K Birkenhäger
November 2024, Swiss medical weekly,
Linda van Diermen, and Seline van den Ameele, and Astrid M Kamperman, and Bernard C G Sabbe, and Tom Vermeulen, and Didier Schrijvers, and Tom K Birkenhäger
August 2005, The Journal of clinical psychiatry,
Linda van Diermen, and Seline van den Ameele, and Astrid M Kamperman, and Bernard C G Sabbe, and Tom Vermeulen, and Didier Schrijvers, and Tom K Birkenhäger
November 2013, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
Linda van Diermen, and Seline van den Ameele, and Astrid M Kamperman, and Bernard C G Sabbe, and Tom Vermeulen, and Didier Schrijvers, and Tom K Birkenhäger
March 2019, Acta psychiatrica Scandinavica,
Linda van Diermen, and Seline van den Ameele, and Astrid M Kamperman, and Bernard C G Sabbe, and Tom Vermeulen, and Didier Schrijvers, and Tom K Birkenhäger
July 2009, Neuroscience letters,
Linda van Diermen, and Seline van den Ameele, and Astrid M Kamperman, and Bernard C G Sabbe, and Tom Vermeulen, and Didier Schrijvers, and Tom K Birkenhäger
September 2018, Acta psychiatrica Scandinavica,
Linda van Diermen, and Seline van den Ameele, and Astrid M Kamperman, and Bernard C G Sabbe, and Tom Vermeulen, and Didier Schrijvers, and Tom K Birkenhäger
October 2015, The Journal of clinical psychiatry,
Linda van Diermen, and Seline van den Ameele, and Astrid M Kamperman, and Bernard C G Sabbe, and Tom Vermeulen, and Didier Schrijvers, and Tom K Birkenhäger
January 2017, Brain stimulation,
Linda van Diermen, and Seline van den Ameele, and Astrid M Kamperman, and Bernard C G Sabbe, and Tom Vermeulen, and Didier Schrijvers, and Tom K Birkenhäger
January 2010, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics,
Linda van Diermen, and Seline van den Ameele, and Astrid M Kamperman, and Bernard C G Sabbe, and Tom Vermeulen, and Didier Schrijvers, and Tom K Birkenhäger
January 1991, Convulsive therapy,
Copied contents to your clipboard!